215 related articles for article (PubMed ID: 15358021)
1. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction.
Sadanandan S; Cannon CP; Chekuri K; Murphy SA; Dibattiste PM; Morrow DA; de Lemos JA; Braunwald E; Gibson CM
J Am Coll Cardiol; 2004 Aug; 44(3):564-8. PubMed ID: 15358021
[TBL] [Abstract][Full Text] [Related]
2. Relation of plasma brain natriuretic peptide levels in non-ST-elevation coronary disease and preserved systolic function to number of narrowed coronary arteries.
Palazzuoli A; Gennari L; Calabria P; Quatrini I; Vecchiato L; De Paola V; Campagna MS; Palazzuoli V; Nuti R
Am J Cardiol; 2005 Dec; 96(12):1705-10. PubMed ID: 16360361
[TBL] [Abstract][Full Text] [Related]
3. B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function.
Palazzuoli A; Maisel A; Caputo M; Fineschi M; Quatrini I; Calabrò A; Campagna MS; Franci B; Grothgar S; Pierli C; Nuti R
Regul Pept; 2011 Feb; 167(1):129-33. PubMed ID: 21237213
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
Morrow DA; de Lemos JA; Sabatine MS; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Gibson CM; Cannon CP; Braunwald E
J Am Coll Cardiol; 2003 Apr; 41(8):1264-72. PubMed ID: 12706919
[TBL] [Abstract][Full Text] [Related]
5. Association between elevated B-type Natriuretic Peptide levels with extent of coronary artery disease in patients with unstable angina and NSTEMI.
Romel SM; Faruque M; Bari MA; Bari MS; Aditya GP; Choudhury AK; Khalequzzaman M; Alam MM; Razzaque MA; Rahman MA; Kabir MS; Ahmed KU; Alam MA
Mymensingh Med J; 2014 Jul; 23(3):544-51. PubMed ID: 25178608
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy.
Mega JL; Morrow DA; De Lemos JA; Sabatine MS; Murphy SA; Rifai N; Gibson CM; Antman EM; Braunwald E
J Am Coll Cardiol; 2004 Jul; 44(2):335-9. PubMed ID: 15261928
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy.
Wiviott SD; Cannon CP; Morrow DA; Murphy SA; Gibson CM; McCabe CH; Sabatine MS; Rifai N; Giugliano RP; DiBattiste PM; Demopoulos LA; Antman EM; Braunwald E
Circulation; 2004 Feb; 109(5):580-6. PubMed ID: 14769678
[TBL] [Abstract][Full Text] [Related]
8. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
9. Validated risk score predicts the development of congestive heart failure after presentation with unstable angina or non-ST-elevation myocardial infarction: results from OPUS-TIMI 16 and TACTICS-TIMI 18.
Wylie JV; Murphy SA; Morrow DA; de Lemos JA; Antman EM; Cannon CP
Am Heart J; 2004 Jul; 148(1):173-80. PubMed ID: 15215808
[TBL] [Abstract][Full Text] [Related]
10. B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.
Goyal BM; Sharma SM; Walia M
Indian Heart J; 2014; 66(2):183-7. PubMed ID: 24814112
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: a TACTICS-TIMI-18 substudy.
Dokainish H; Pillai M; Murphy SA; DiBattiste PM; Schweiger MJ; Lotfi A; Morrow DA; Cannon CP; Braunwald E; Lakkis N;
J Am Coll Cardiol; 2005 Jan; 45(1):19-24. PubMed ID: 15629367
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non-ST-elevation coronary syndromes and preserved systolic function.
Palazzuoli A; Deckers J; Calabrò A; Campagna MS; Nuti R; Pastorelli M; Pasqui AL; Bruni F; Auteri A; Puccetti L
Am J Cardiol; 2006 Nov; 98(10):1322-8. PubMed ID: 17134622
[TBL] [Abstract][Full Text] [Related]
13. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy.
Sabatine MS; Morrow DA; Cannon CP; Murphy SA; Demopoulos LA; DiBattiste PM; McCabe CH; Braunwald E; Gibson CM
J Am Coll Cardiol; 2002 Nov; 40(10):1761-8. PubMed ID: 12446059
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clinical risk assessment systems in predicting three-vessel coronary artery disease and angiographic culprit lesion in patients with non-ST segment elevated myocardial infarction/unstable angina pectoris.
Isilak Z; Kardesoglu E; Aparci M; Uz O; Yalcin M; Yiginer O; Cingozbay BY; Uzun M
Kardiol Pol; 2012; 70(3):242-50. PubMed ID: 22430403
[TBL] [Abstract][Full Text] [Related]
15. Plasma B-type natriuretic peptide level can predict myocardial tissue perfusion in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Seo SM; Kim S; Chang K; Min J; Kim TH; Koh YS; Park HJ; Shin WS; Lee JM; Kim PJ; Chung WS; Seung KB
Coron Artery Dis; 2011; 22(6):405-10. PubMed ID: 21701385
[TBL] [Abstract][Full Text] [Related]
16. B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function.
Palazzuoli A; Caputo M; Fineschi M; Navarri R; Calabrò A; Cameli M; Campagna MS; Franci B; Pierli C; Nuti R; Maisel A
Eur J Prev Cardiol; 2012 Jun; 19(3):366-73. PubMed ID: 21464097
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of B-type natriuretic Peptide in patients with unstable angina pectoris or acute myocardial infarction: prognostic significance and therapeutic implications.
Ahmed W; Zafar S; Alam AY; Ahktar N; Shah MA; Alpert MA
Angiology; 2007; 58(3):269-74. PubMed ID: 17626979
[TBL] [Abstract][Full Text] [Related]
18. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level.
Choi EY; Kwon HM; Yoon YW; Kim D; Kim HS
Yonsei Med J; 2004 Apr; 45(2):255-62. PubMed ID: 15118997
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction.
Hong SN; Ahn Y; Hwang SH; Yoon NS; Lee SR; Moon JY; Kim KH; Hong YJ; Park HW; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Aug; 100(4):631-4. PubMed ID: 17697819
[TBL] [Abstract][Full Text] [Related]
20. B-type natriuretic peptide as a predictor of ischemia/reperfusion injury immediately after myocardial reperfusion in patients with ST-segment elevation acute myocardial infarction.
Arakawa K; Himeno H; Kirigaya J; Otomo F; Matsushita K; Nakahashi H; Shimizu S; Nitta M; Takamizawa T; Yano H; Endo M; Kanna M; Kimura K; Umemura S
Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):62-70. PubMed ID: 25609593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
